Brian Lee Baker Turning Point Therapeutics, Inc. (TPTX) insider trading activity

Brian Lee Baker is SVP of Finance and Admin. of Turning Point Therapeutics, Inc.. Currently has a direct ownership of 4,116 shares of TPTX, which is worth approximately $0. The most recent transaction as insider was on Mar 23, 2021, when has been sold 28,435 shares (Common Stock) at a price of $100.99 per share, resulting in proceeds of $2,871,651. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 4.12K

0% 3M change

0% 12M change

Total Value Held $0

Brian Lee Baker Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 23 2021	SELL Open market or private sale	$2,871,651 $100.99 p/Share	28,435 Reduced 87.36%	4,116 Common Stock
Mar 23 2021	BUY Exercise of conversion of derivative security	$127,673 $4.49 p/Share	28,435 Added 46.63%	32,551 Common Stock
Mar 22 2021	BUY Grant, award, or other acquisition	-	1,625 Added 28.31%	4,116 Common Stock
Feb 08 2021	BUY Grant, award, or other acquisition	-	1,483 Added 37.32%	2,491 Common Stock
Jan 07 2021	SELL Open market or private sale	$3,810,099 $121.97 p/Share	31,238 Reduced 96.87%	1,008 Common Stock
Jan 07 2021	BUY Exercise of conversion of derivative security	$127,687 $4.49 p/Share	28,438 Added 46.86%	32,246 Common Stock
Dec 10 2019	BUY Grant, award, or other acquisition	$6,724 $31.13 p/Share	216 Added 6.68%	3,016 Common Stock
Apr 22 2019	BUY Open market or private purchase	$50,400 $18.0 p/Share	2,800 Added 50.0%	2,800 Common Stock

BLB

Brian Lee Baker

SVP of Finance and Admin.

San Diego, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TPTX shares.

Notify only if

Value

Insider Trading

Get notified when an Turning Point Therapeutics, Inc. insider buys or sells TPTX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Turning Point Therapeutics, Inc.

Track Activities on TPTX

Account